GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nath Bio-Genes (India) Ltd (BOM:537291) » Definitions » Marketable Securities

Nath Bio-Genes (India) (BOM:537291) Marketable Securities : ₹1,629 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nath Bio-Genes (India) Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nath Bio-Genes (India)'s Marketable Securities for the quarter that ended in Mar. 2024 was ₹1,629 Mil.

Nath Bio-Genes (India)'s annual Marketable Securities increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹1,709 Mil) but then declined from Mar. 2023 (₹1,709 Mil) to Mar. 2024 (₹1,629 Mil).


Nath Bio-Genes (India) Marketable Securities Historical Data

The historical data trend for Nath Bio-Genes (India)'s Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nath Bio-Genes (India) Marketable Securities Chart

Nath Bio-Genes (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,709.29 1,629.39

Nath Bio-Genes (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,709.29 - 1,696.78 - 1,629.39

Nath Bio-Genes (India) Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Nath Bio-Genes (India)  (BOM:537291) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Nath Bio-Genes (India) Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nath Bio-Genes (India)'s Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nath Bio-Genes (India) (BOM:537291) Business Description

Traded in Other Exchanges
Address
Nath House, Nath Road, Chhatrapati Sambhajinagar, MH, IND, 431005
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.

Nath Bio-Genes (India) (BOM:537291) Headlines

No Headlines